Validation of the new PROGRESS‐CTO complication risk scores in the OPEN‐CTO registry

Author:

Azzalini Lorenzo1,Hirai Taishi2,Salisbury Adam3ORCID,Gosch Kensey3,Sapontis James4,Nicholson William J.5,Karmpaliotis Dimitri6,Moses Jeffrey W.78,Kearney Kathleen E.1,Lombardi William L.1,Grantham James Aaron3

Affiliation:

1. Department of Medicine, Division of Cardiology University of Washington Seattle Washington USA

2. Department of Medicine, Division of Cardiology University of Missouri Columbia Missouri USA

3. Saint Luke's Mid America Heart Institute Kansas City Missouri USA

4. Monash Heart Monash University Melbourne Australia

5. Department of Medicine, Division of Cardiology Emory University Atlanta Georgia USA

6. Gagnon Cardiovascular Institute, Morristown Medical Center Morristown New Jersey USA

7. New York Presbyterian Hospital Columbia University New York New York USA

8. St. Francis Hospital & Heart Center Roslyn New York USA

Abstract

AbstractBackgroundRisk stratification before chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is important to inform procedural planning as well as patients and their families. We sought to externally validate the PROGRESS‐CTO complication risk scores in the OPEN‐CTO registry.MethodsOPEN‐CTO is a prospective registry of 1000 consecutive CTO PCIs performed at 12 experienced US centers using the hybrid algorithm. Endpoints of interest were in‐hospital all‐cause mortality, need for pericardiocentesis, acute myocardial infarction (MI), and major adverse cardiovascular events (MACE) (a composite of all‐cause mortality, stroke, periprocedural MI, urgent repeat revascularization, and tamponade requiring pericardiocentesis). Model discrimination was assessed with the area under the curve (AUC) method, and calibration with the observed‐versus‐predicted probability method.ResultsMean age was 65.4 ± 10.3 year, and 36.5% of patients had prior coronary artery bypass graft. Overall, 41 patients (4.1%) suffered MACE, 9 (0.9%) mortality, 26 (2.6%) acute MI, and 11 (1.1%) required pericardiocentesis. Technical success was achieved in 86.3%. Patients who experienced MACE had higher anatomic complexity, and more often required antegrade dissection/reentry and the retrograde approach. Increasing PROGRESS‐CTO MACE scores were associated with increasing MACE rates: 0.5% (score 0−1), 2.4% (score 2), 3.7% (score 3), 4.5% (score 4), 7.8% (score 5), 13.0% (score 6−7). The AUC were as follows: MACE 0.72 (95% confidence interval [CI]: 0.66−0.78), mortality 0.79 (95% CI: 0.66−0.95), pericardiocentesis 0.71 (95% CI: 0.60−0.82), and acute MI 0.57 (95% CI: 0.49−0.66). Calibration was adequate for MACE and mortality, while the models underestimated the risk of pericardiocentesis and acute MI.ConclusionsIn a large external cohort of patients treated with the hybrid algorithm by experienced CTO operators, the PROGRESS‐CTO MACE, mortality, and pericardiocentesis risk scores showed good discrimination, while the acute MI score had inferior performance.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3